Table 3.

Baseline and Follow-up Carotid Measures

	Standard Group (S) N=204	Aggressive Group N=223			Bonferroni Adjusted
		Ezetimibe(E+)	No Ezetimibe(E−)	F test(p- value)	Group Diff. (p-value) E+ vs E−	Group Diff. (p-value) E+ vs S	Group Diff. (p-value) E− vs S
	Mean (95% CI)	Mean (95% CI)	Mean (95% CI)
CIMT (mm)
Baseline	.794 (.77,.82)	.819 (.77,.86)	.813 (.78,.84)	.46
18 mo	.803 (.78–.82)	.815(.78–.86)	.810 (.78–.84)	.84
36 mo	.833(.81–.86)	.794 (.75,.84)	.801 (.77,.83)	.17
Mean Change,18 mo	.009 (−.01,.03)	−.006(−.03,.02)	−.005(.02,.014)	.48
Mean Change, 36 mo	.039 (.02,.06)	−.025(−.05,.003)	−.012(.03,.008)	.0001	.01(.999)	.06(.001)	.05(.001)
Plaque Score
Baseline	1.83 (1.6,2.1)	1.93 (1.5,2.3)	1.88 (1.6,2.1)	.89
18 mo	2.02 (1.8,2.2)	2.10 (1.7,2.5)	2.11 (1.9,2.4)	.84
36 mo	2.33 (2.1,2.6)	2.35 (1.9,2.8)	2.49 (2.2,2.8)	.65
Mean Change, 18 mo	.18 (.04,.3)	.17 (−.04,.4)	.21 (.06,.4)	.94
Mean Change, 36 mo	.51 (.4,.7)	.42 (.1,.7)	.61 (.4,.8)	.50

Abbreviations: E+ = ezetimibe subgroup; E− = no ezetimibe subgroup; CIMT = carotid artery intimal medial thickness; S = standard group.